lobbying_activities: 1223166

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1223166	d41ea8ee-2ce0-4a60-acde-95f7ac11fbaf	Q1	HOLLAND & KNIGHT LLP	18466	ALLIANCE FOR REGENERATIVE MEDICINE	2012	first_quarter	HCR	Advocate for creation of federal coordinating entity for regenerative medicine. Met with NIH officals regarding same; Advocate for new/modified regulations regarding FDA approval of regenerative medicine products. Spoke with FDA officials about same. Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011. Lobbied Congress to have provisions inserted in PDUFA reauthorization Energy & Commerce Committee draft legislation.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE	80000		0	0	2012-04-03T13:06:44.553000-04:00